South Rampart Pharma
Phase 2South Rampart Pharma, Inc. is a clinical-stage life science biotech company focused on advancing innovative small molecules designed to overcome the risks of current pain medicines.
Founded
2018
Focus
Small Molecules
About
South Rampart Pharma, Inc. is a clinical-stage life science biotech company focused on advancing innovative small molecules designed to overcome the risks of current pain medicines.
Funding History
2Total raised: $20M
Series A$15MUndisclosedMar 15, 2022
Seed$5MUndisclosedOct 15, 2020
Company Info
TypePrivate
Founded2018
LocationNew Orleans, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile